Zafirlukast
Respiratory System
Cromoglycate, leukotriene and phosphodesterase type-4 inhib
BNF 0303020Z0
Data updated April 2026
Download CSV
Zafirlukast was ranked 1642nd of 1,792 medicines by items in April 2026, with 3 items, up 200.0% on a year earlier.
3items
+200%
Dispensed in April 2026
18items
Rolling 12 months
£1,230
Net ingredient cost · April 2026
Figure 1. Zafirlukast: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to April 2026
Embed this chart
At a glance
- Therapeutic class Cromoglycate, leukotriene and phosphodesterase type-4 inhib
- Presentations 1 shown
- Average cost / item £410.00
- Year on year Up 200.0% on a year earlier
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.
Top presentations, April 2026
The individual products dispensed under Zafirlukast this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Zafirlukast 20mg tablets | 0303020Z0AAABAB | 3 | £1,230 |
Source: NHSBSA Prescription Cost Analysis · to April 2026 OGL v3.0
Where Zafirlukast is dispensed
The regions and dispensing practices with the highest Zafirlukast volumes.
Top regions
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Zafirlukast with
Other medicines in the same BNF section, by prescribing volume.